App is temporarily unavailable

Therapiealgorithmen Onkologie

Published by: rs media

In-Apps

Kapitel: CAT
$3.99
Kapitel: Gliome
$3.99
Kapitel: Analkarzinom
$3.99
Bronchialkarzinom (NSCLC)
$3.99
Kapitel: Ewing-Tumoren
$3.99
Kapitel: Endometriumkarzinom
$3.99
Kapitel: Gallenwegskarzinom
$3.99
Kapitel: Bronchialkarzinom (SCLC)
$5.99
Kapitel: Gastrointestinale Stromatumoren (GIST)
$3.99

Therapiealgorithmen Onkologie FAQ

  • Is Therapiealgorithmen Onkologie free?

    Yes, Therapiealgorithmen Onkologie is free to download, however it contains in-app purchases or subscription offerings.

  • Is Therapiealgorithmen Onkologie legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Therapiealgorithmen Onkologie cost?

    Therapiealgorithmen Onkologie has several in-app purchases/subscriptions, the average in-app price is $4.21.

  • What is Therapiealgorithmen Onkologie revenue?

    To get estimated revenue of Therapiealgorithmen Onkologie app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Kuwait yet.
Ratings History

Therapiealgorithmen Onkologie Reviews

No Reviews in Kuwait
App doesn't have any reviews in Kuwait yet.

Therapiealgorithmen Onkologie Competitors

Name
Biosimilars onkowissen
Lungenkarzinome onkowissen
Immunonkologie onkowissen
Multiples Myelom onkowissen
Präzisionsonkowissen
upper GI onkowissen
HCC onkowissen
CRC onkowissen
Non-Hodgkin-Lymphom onkowissen
Kopf-Hals-Tumoren onkowissen

Therapiealgorithmen Onkologie Installs

Last 30 days

Therapiealgorithmen Onkologie Revenue

Last 30 days

Therapiealgorithmen Onkologie Revenue and Downloads

Gain valuable insights into Therapiealgorithmen Onkologie performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Publisher
rs media
Languages
English
Recent release
1.8.1 (3 years ago )
Released on
Nov 4, 2011 (13 years ago )
Last Updated
1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.